These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4607873)

  • 21. Evidence of an efflux pump in Serratia marcescens.
    Berlanga M; Vázquez JL; Hernandez-Borrell J; Montero MT; Viñas M
    Microb Drug Resist; 2000; 6(2):111-7. PubMed ID: 10990265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reliability of the colistin disk test in identification of Serratia marcescens and Serratia liquefaciens.
    von Graevenitz A; Zollinger-Iten J
    Eur J Clin Microbiol; 1987 Feb; 6(1):70-1. PubMed ID: 3032610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro synergistic effects of fisetin and norfloxacin against aquatic isolates of Serratia marcescens.
    Dong J; Ruan J; Xu N; Yang Y; Ai X
    FEMS Microbiol Lett; 2016 Jan; 363(1):fnv220. PubMed ID: 26567906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic susceptibility of Serratia marcescens and Serratia liquefaciens.
    Traub WH
    Chemotherapy; 2000; 46(5):315-21. PubMed ID: 10965096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temperature-sensitive mutants of serratia phage Kappa.
    Wackernagel W; Winkler R
    Virology; 1970 Nov; 42(3):777-9. PubMed ID: 4921687
    [No Abstract]   [Full Text] [Related]  

  • 26. Decreased susceptibility of Serratia marcescens to chlorhexidine related to the inner membrane.
    Lannigan R; Bryan LE
    J Antimicrob Chemother; 1985 May; 15(5):559-65. PubMed ID: 3891711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Site-directed mutagenesis studies to probe the role of specific residues in the external loop (L3) of OmpF and OmpC porins in susceptibility of Serratia marcescens to antibiotics.
    Begic S; Worobec EA
    Can J Microbiol; 2007 Jun; 53(6):710-9. PubMed ID: 17668031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The induction of mutations in Streptomyces aureofaciens by UV rays and nitrosoguanidine and the identification of the mutants obtained].
    Lavrinchuk VIa; Stryzhkova HM; Matseliukh BP
    Mikrobiol Z; 1997; 59(2):20-4. PubMed ID: 9221058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation of a Serratia marcescens mutant which is an efficient recipient for the E. coli episome.
    Takata R; Aoyagi M
    Mol Gen Genet; 1984; 197(3):517-8. PubMed ID: 6396497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical mutagenesis in Serratia phage kappa.
    Saha N; Bode SK
    Indian J Exp Biol; 1967 Oct; 5(4):241-2. PubMed ID: 4868745
    [No Abstract]   [Full Text] [Related]  

  • 31. Induced mutations in Serratia marcescens by near UV-light in presence of psoralen.
    Joseph R; Shanthamma MS; Rehana F; Nand K
    Experientia; 1974 Apr; 30(4):360-1. PubMed ID: 4600669
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibiotic resistance in Serratia marcescens.
    Tompkins DS; Lacey RW; Pitts-Tucker TJ
    Br Med J (Clin Res Ed); 1984 Jan; 288(6411):148-9. PubMed ID: 6419826
    [No Abstract]   [Full Text] [Related]  

  • 33. Conditions required for the bactericidal activity of 4-quinolones against Serratia marcescens.
    Lewin CS; Smith JT
    J Med Microbiol; 1990 Jul; 32(3):211-4. PubMed ID: 2165168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Killing of Serratia marcescens biofilms with chloramphenicol.
    Ray C; Shenoy AT; Orihuela CJ; González-Juarbe N
    Ann Clin Microbiol Antimicrob; 2017 Mar; 16(1):19. PubMed ID: 28356113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical studies on urinary tract infections caused by Serratia marcescens. I. Clinical and bacteriological studies on urinary tract infections caused by Serratia marcescens].
    Sakai S; Kumamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1983 Apr; 74(4):467-84. PubMed ID: 6353020
    [No Abstract]   [Full Text] [Related]  

  • 36. [The influence of the antivitamine pyrithiamine on the metabolism of the thiamin-autotrophic Serratia marcescens].
    Hagedorn H; Schmidt OR
    Arch Microbiol; 1975 Mar; 103(1):83-8. PubMed ID: 1100010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ciprofloxacin-resistant Serratia marcescens.
    Malvone L
    Infect Control Hosp Epidemiol; 1991 Jun; 12(6):342. PubMed ID: 2071875
    [No Abstract]   [Full Text] [Related]  

  • 38. Tellurium resistance in nosocomial isolates of Serratia marcescens.
    Guevara Guzmán M; de Ramírez Y; Pedroza R; Rodríquez Lemoine V
    Acta Cient Venez; 1989; 40(5-6):392-3. PubMed ID: 2520353
    [No Abstract]   [Full Text] [Related]  

  • 39. Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.
    Traub WH
    Chemotherapy; 1985; 31(1):34-9. PubMed ID: 3156026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aminoglycoside resistance patterns of Serratia marcescens strains of clinical origin.
    Coria-Jiménez R; Ortiz-Torres C
    Epidemiol Infect; 1994 Feb; 112(1):125-31. PubMed ID: 8119351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.